Clinical Performance and Safety of the Unicompartmental Univation® XF Pro Implant

NCT06657248 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 150

Last updated 2026-05-08

No results posted yet for this study

Summary

The study is designed as a prospective, observational, mid-term, multi-center follow-up study. It is planned to include 150 patients from 4 different study centres in Germany.

Conditions

  • Gonarthritis
  • Degenerative Disease

Interventions

DEVICE

univation® XF Pro

Primary medial unicompartmental knee arthroplasty

Sponsors & Collaborators

  • Raylytic GmbH

    collaborator INDUSTRY
  • Aesculap AG

    lead INDUSTRY

Principal Investigators

  • Rolf Haaker, Prof. Dr. · St. Vincenz Hospital Brakel

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-04-02
Primary Completion
2027-10-31
Completion
2032-10-31

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06657248 on ClinicalTrials.gov